Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.47 |
| ▸ | GLA | P06280 | 1/20 | 0.47 |
| ▸ | TP53 | P04637 | 3/20 | 0.42 |
| ▸ | TSHR | P16473 | 3/20 | 0.42 |
| ▸ | HIF1A | Q16665 | 2/20 | 0.42 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.42 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.42 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.40 |
| ▸ | SLC6A2 | P23975 | 2/20 | 0.33 |
| ▸ | HTR2A | P28223 | 2/20 | 0.33 |
| ▸ | SLC6A4 | P31645 | 2/20 | 0.33 |
| ▸ | HTR2B | P41595 | 2/20 | 0.33 |
| ▸ | SLC6A3 | Q01959 | 2/20 | 0.33 |
| ▸ | ADRB2 | P07550 | 1/20 | 0.33 |
| ▸ | HTR1A | P08908 | 1/20 | 0.33 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.33 |
| ▸ | ADRA2C | P18825 | 1/20 | 0.33 |
| ▸ | MEN1 | O00255 | 2/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.33 |
| ▸ | MAPT | P10636 | 2/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2008231 | 0.89 | ALDH1A1 (0.55) | ALDH1A1GLATP53TSHRHIF1A | |
| SCHEMBL3757275 | 0.88 | ALDH1A1 (0.41) | ALDH1A1GLATP53TSHRHIF1A | |
| SCHEMBL2423565 | 0.84 | ALDH1A1 (0.53) | ALDH1A1GLATP53TSHRHIF1A | |
| SCHEMBL2427332 | 0.84 | ALDH1A1 (0.47) | ALDH1A1GLATP53TSHRHIF1A | |
| SCHEMBL3762678 | 0.83 | ALDH1A1 (0.42) | ALDH1A1GLATP53TSHRHIF1A | |
| SCHEMBL2420881 | 0.82 | ALDH1A1 (0.44) | ALDH1A1GLATP53TSHRHIF1A | |
| SCHEMBL3761864 | 0.80 | ALDH1A1 (0.51) | ALDH1A1GLATP53TSHRHIF1A | |
| SCHEMBL3759755 | 0.80 | ALDH1A1 (0.41) | ALDH1A1GLATP53TSHRHIF1A | |
| SCHEMBL680532 | 0.79 | ALDH1A1 (0.65) | ALDH1A1GLATP53TSHRHIF1A | |
| SCHEMBL3759495 | 0.78 | ALDH1A1 (0.47) | ALDH1A1GLATP53TSHRHIF1A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8084650-B2 | Adamantane derivative, resin composition containing same, and optoelectronic member and sealing agent for electronic circuit using those | IDEMITSU KOSAN CO., LTD. (JP) | 2011-12-27 | — | — | US | disclosed |
| US-8017800-B2 | Adamantyl group-containing epoxy-modified (meth)acrylate and resin composition containing the same | IDEMITSU KOSAN CO., LTD. (JP) | 2011-09-13 | — | — | US | disclosed |
| US-20100298491-A1 | ADAMANTANE DERIVATIVE, RESIN COMPOSITION CONTAINING SAME, AND OPTOELECTRONIC MEMBER AND SEALING AGENT FOR ELECTRONIC CIRCUIT USING THOSE | IDEMITSU KOSAN CO., LTD. (JP) | 2010-11-25 | — | — | US | disclosed |
| US-20100274043-A1 | ADAMANTYL GROUP-CONTAINING EPOXY-MODIFIED (METH)ACRYLATE AND RESIN COMPOSITION CONTAINING THE SAME | IDEMITSU KOSAN CO., LTD. (JP) | 2010-10-28 | — | — | US | disclosed |
| US-7790917-B2 | Adamantyl group-containing epoxy-modified (meth)acrylate and resin composition containing the same | IDEMITSU KOSAN CO., LTD. (JP) | 2010-09-07 | — | — | US | disclosed |
| US-20090099330-A1 | ADAMANTYL GROUP-CONTAINING EPOXY-MODIFIED (METH)ACRYLATE AND RESIN COMPOSITION CONTAINING THE SAME | IDEMITSU KOSAN CO., LTD. (JP) | 2009-04-16 | — | — | US | disclosed |
| EP-2014691-A1 | ADAMANTYL GROUP-CONTAINING EPOXY-MODIFIED (METH)ACRYLATE AND RESIN COMPOSITION CONTAINING THE SAME | Idemitsu Kosan Co., Ltd. (JP) | 2009-01-14 | — | — | EP | disclosed |
| EP-1985616-A1 | ADAMANTANE DERIVATIVE, RESIN COMPOSITION CONTAINING SAME, AND OPTOELECTRONIC MEMBER AND SEALING AGENT FOR ELECTRONIC CIRCUIT USING THOSE | Idemitsu Kosan Co., Ltd. (JP) | 2008-10-29 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100298491-A1 | ADAMANTANE DERIVATIVE, RESIN COMPOSITION CONTAINING SAME, AND OPTOELECTRONIC MEMBER AND SEALING AGENT FOR ELECTRONIC CIRCUIT USING THOSE | AOC1, ASIC1, ICAM1 | ALDH1A1 10/4885GLA 2037/4885TP53 4522/4885 |
| US-20100274043-A1 | ADAMANTYL GROUP-CONTAINING EPOXY-MODIFIED (METH)ACRYLATE AND RESIN COMPOSITION CONTAINING THE SAME | TAS2R42, MEP1A, TAS2R41 | ALDH1A1 219/4885GLA 4337/4885TP53 4246/4885 |
| US-20090099330-A1 | ADAMANTYL GROUP-CONTAINING EPOXY-MODIFIED (METH)ACRYLATE AND RESIN COMPOSITION CONTAINING THE SAME | TAS2R42, MEP1A, TAS2R41 | ALDH1A1 227/4885GLA 4350/4885TP53 4276/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.